Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-10-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2020.30 |
| _version_ | 1797200045120946176 |
|---|---|
| author | Despoina-Rafailia Benetou Charalampos Varlamos Christos Pappas Fotios Kolokathis Dimitrios Alexopoulos |
| author_facet | Despoina-Rafailia Benetou Charalampos Varlamos Christos Pappas Fotios Kolokathis Dimitrios Alexopoulos |
| author_sort | Despoina-Rafailia Benetou |
| collection | DOAJ |
| description | Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients has long been considered a challenge for clinicians. This is because the beneficial effects of prolonged treatment and/or more potent antiplatelet agents’ use in preventing ischemic events are hindered by a concomitant increase in bleeding complications. The aim of this review is to highlight current evidence regarding the optimal antithrombotic therapy regimens used in complex PCI patients, focusing on the evaluation of both safety and efficacy outcomes as well as addressing future perspectives. |
| first_indexed | 2024-03-07T17:40:51Z |
| format | Article |
| id | doaj.art-5b6f64e6a44a4cc9b162c9ac93c3aff0 |
| institution | Directory Open Access Journal |
| issn | 1758-3896 1758-390X |
| language | English |
| last_indexed | 2024-04-24T07:25:24Z |
| publishDate | 2021-10-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | US Cardiology Review |
| spelling | doaj.art-5b6f64e6a44a4cc9b162c9ac93c3aff02024-04-20T16:02:24ZengRadcliffe Medical MediaUS Cardiology Review1758-38961758-390X2021-10-011510.15420/usc.2020.30Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of TreatmentDespoina-Rafailia Benetou0Charalampos Varlamos1Christos Pappas2Fotios Kolokathis3Dimitrios Alexopoulos4Second Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, GreeceSecond Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, GreeceSecond Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, GreeceSecond Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, GreeceSecond Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, GreecePatients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients has long been considered a challenge for clinicians. This is because the beneficial effects of prolonged treatment and/or more potent antiplatelet agents’ use in preventing ischemic events are hindered by a concomitant increase in bleeding complications. The aim of this review is to highlight current evidence regarding the optimal antithrombotic therapy regimens used in complex PCI patients, focusing on the evaluation of both safety and efficacy outcomes as well as addressing future perspectives.https://www.uscjournal.com/articleindex/usc.2020.30 |
| spellingShingle | Despoina-Rafailia Benetou Charalampos Varlamos Christos Pappas Fotios Kolokathis Dimitrios Alexopoulos Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment US Cardiology Review |
| title | Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment |
| title_full | Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment |
| title_fullStr | Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment |
| title_full_unstemmed | Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment |
| title_short | Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment |
| title_sort | antithrombotics in complex percutaneous coronary interventions type and duration of treatment |
| url | https://www.uscjournal.com/articleindex/usc.2020.30 |
| work_keys_str_mv | AT despoinarafailiabenetou antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT charalamposvarlamos antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT christospappas antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT fotioskolokathis antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT dimitriosalexopoulos antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment |